5 Best US Stocks to Buy and Hold for the Next 3 Years

Page 5 of 5

1. Eli Lilly and Company (NYSE:LLY)

Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold for the next 3 years. On March 31, Eli Lilly announced an agreement to acquire Centessa Pharmaceuticals in a deal valued at $7.8 billion. The acquisition diversifies the company’s portfolio beyond metabolic treatments and establishes a presence in the sleep disorder market. Eli Lilly has offered $38 per share in cash, representing a 37.8% premium over Centessa’s recent closing price, along with a contingent value right worth ~$9 per share.

The acquisition focuses on Centessa’s development of orexin agonists, a new class of treatments designed to regulate the brain’s sleep-wake cycle. The company’s lead drug candidate, cleminorexton, is currently in mid-stage clinical studies for the treatment of narcolepsy and idiopathic hypersomnia.

Analysts suggest that the market for narcolepsy drugs, currently valued at $2.5 billion, could expand with the introduction of these types of high-performance medical solutions. This deal follows several recent acquisitions by Eli Lilly and Company (NYSE:LLY) and aligns with the company’s efforts to address the widespread impact of sleep disorders, which affect an estimated 50 million to 70 million Americans.

Eli Lilly and Company (NYSE:LLY) is a healthcare company that specializes in human pharmaceutical products and offers cardiometabolic health & oncology products.

While we acknowledge the potential of LLY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LLY and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5